• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

REGENERON PHARMACEUTICALS, INC.

Notes

No. Proposition For Against Abstain
1

Election of Director: Joseph L. Goldstein, M.D.

2

Election of Director: Christine A. Poon

3

Election of Director: David P. Schenkein, M.D.

4

Election of Director: Craig B. Thompson, M.D.

5

Election of Director: Huda Y. Zoghbi, M.D.

6

Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

7

Proposal to approve, on an advisory basis, compensation of the Named Executive Officers.